AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2022
Oct 3, 2022
33341_dirs_2022-10-03_a45bd7fb-4e62-4329-b57e-e110757fc3c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRC)
CIK: 0000070487
Period of Report: 2022-09-29
Reporting Person: RAASCH JONA S (COO, NRC Health)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-29 | Common Stock | M | 23581 | $13.17 | Acquired | 23581 | Direct |
| 2022-09-29 | Common Stock | F | 12318 | $40.66 | Disposed | 11263 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-29 | Employee Stock Option (Right to Buy) | $13.17 | M | 23581 | Disposed | 2025-01-06 | Common Stock (23581) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 50619 | Indirect |
Footnotes
F1: This option became fully exercisable on January 6, 2020.
More from NATIONAL RESEARCH CORP
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 18